An email has been sent to your address with instructions for changing your password.
There is no user registered with this email.
Sign Up
To create a free account, please fill out the form below.
Thank you for signing up!
A confirmation email has been sent to your email address. Please check your email and follow the instructions in the message to complete the registration process. If you do not receive the email, please check your spam folder or contact us for assistance.
Welcome to our platform!
Oops!
Something went wrong while trying to create your new account. Please try again and if the problem persist, Email Us to receive support.
MIMEDX to Present at TD Cowen 44th Annual Health Care Conference
Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
conferences
Rhea-AI Summary
MiMedx Group, Inc. (MDXG) announces participation in TD Cowen 44th Annual Health Care Conference. Senior management to present on March 4, 2024, at 2:10 PM ET. Webcast available for institutional investors. Replay to follow on Company's website.
Positive
None.
Negative
None.
MARIETTA, Ga., Feb. 20, 2024 (GLOBE NEWSWIRE) -- MiMedx Group, Inc. (Nasdaq: MDXG) (“MIMEDX” or the “Company”) today announced that senior management will participate in the TD Cowen 44th Annual Health Care Conference.
TD Cowen | Boston, MA | March 4-6, 2024 Presentation: Monday, March 4, 2024 at 2:10 PM ET Webcast: Click here to access
Institutional investors interested in meeting with senior management may contact their TD Cowen representative.
A live webcast of the presentation will be available on the Events page of the Investors section of the Company’s website at www.mimedx.com or through the conference site by using the link above. A replay will be available on the Company’s website following the event.
About MIMEDX MIMEDX is a pioneer and leader focused on helping humans heal. With more than a decade of helping clinicians manage chronic and other hard-to-heal wounds, MIMEDX is dedicated to providing a leading portfolio of products for applications in the wound care, burn, and surgical sectors of healthcare. The Company’s vision is to be the leading global provider of healing solutions through relentless innovation to restore quality of life. For additional information, please visit www.mimedx.com.
When is MiMedx Group, Inc. presenting at the TD Cowen 44th Annual Health Care Conference?
MiMedx Group, Inc. is presenting on Monday, March 4, 2024, at 2:10 PM ET.
Where can institutional investors access the webcast of the presentation?
Institutional investors can access the webcast on the Events page of the Investors section of the Company's website at www.mimedx.com or through the conference site using the provided link.
Will there be a replay of the presentation available?
Yes, a replay of the presentation will be available on the Company's website following the event.
How can institutional investors schedule a meeting with senior management?
Institutional investors interested in meeting with senior management may contact their TD Cowen representative.
mimedx® is an industry leader in advanced wound care and a therapeutic biologics company developing and distributing human placental tissue allografts with patent-protected processes for multiple sectors of healthcare. the company processes the human placental tissue utilizing its proprietary purion® process methodology, among other processes, to produce allografts by employing aseptic processing techniques in addition to terminal sterilization. mimedx has supplied more than two million allografts, through both direct and consignment shipments. for additional information, please visit www.mimedx.com.